These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda. Kagaayi J; Makumbi F; Nakigozi G; Wawer MJ; Gray RH; Serwadda D; Reynolds SJ AIDS; 2007 May; 21(9):1208-10. PubMed ID: 17502733 [TBL] [Abstract][Full Text] [Related]
25. Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Jamieson DJ; Clark J; Kourtis AP; Taylor AW; Lampe MA; Fowler MG; Mofenson LM Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S26-32. PubMed ID: 17825647 [TBL] [Abstract][Full Text] [Related]
26. Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, Uganda. Spacek LA; Gray RH; Wawer MJ; Sewankambo NK; Serwadda D; Wabwire-Mangen F; Kiwanuka N; Kigozi G; Nalugoda F; Quinn TC; Int J STD AIDS; 2006 Feb; 17(2):116-20. PubMed ID: 16464274 [TBL] [Abstract][Full Text] [Related]
27. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment. Bwire R; Nagelkerke NJ; Borgdorff MW Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731 [TBL] [Abstract][Full Text] [Related]
28. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650 [TBL] [Abstract][Full Text] [Related]
29. Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need? Torpey K; Lartey M; Amenyah R; Addo NA; Obeng-Baah J; Rahman Y; Suzuki C; Mukadi YD; Colebunders R Int J STD AIDS; 2009 Jun; 20(6):395-8. PubMed ID: 19451324 [TBL] [Abstract][Full Text] [Related]
30. Comparison of previous and present World Health Organization clinical staging criteria in HIV-infected Malawian children. Poerksen G; Nyirenda M; Pollock L; Blencowe H; Tembo P; Chesshyre E; Jefferis O; Kenny J; Moons P; Bunn J; Molyneux E AIDS; 2009 Sep; 23(14):1913-6. PubMed ID: 19584702 [TBL] [Abstract][Full Text] [Related]
31. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy. Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087 [TBL] [Abstract][Full Text] [Related]
32. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005. Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S; Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319 [TBL] [Abstract][Full Text] [Related]
33. The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients. Olawumi HO; Olatunji PO HIV Med; 2006 Sep; 7(6):351-5. PubMed ID: 16903978 [TBL] [Abstract][Full Text] [Related]
34. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327 [TBL] [Abstract][Full Text] [Related]
35. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières. Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610 [TBL] [Abstract][Full Text] [Related]
36. Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences. Abrams EJ; Myer L; Rosenfield A; El-Sadr WM Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S101-6. PubMed ID: 17825640 [TBL] [Abstract][Full Text] [Related]
37. IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment. Bento CA; Hygino J; Andrade RM; Saramago CS; Silva RG; Silva AA; Linhares UC; Brindeiro R; Tanuri A; Rosenzwajg M; Klatzmann D; Andrade AF AIDS; 2009 Jan; 23(1):9-18. PubMed ID: 19050381 [TBL] [Abstract][Full Text] [Related]
38. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. Carter RJ; Dugan K; El-Sadr WM; Myer L; Otieno J; Pungpapong N; Toro PL; Abrams EJ; J Acquir Immune Defic Syndr; 2010 Nov; 55(3):404-10. PubMed ID: 20595905 [TBL] [Abstract][Full Text] [Related]
39. Prevention of human immunodeficiency virus mother-to-child transmission in Israel. Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889 [TBL] [Abstract][Full Text] [Related]